Journal
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
Volume 35, Issue 2, Pages 62-67Publisher
FRONTLINE MEDICAL COMMUNICATIONS
DOI: 10.12788/j.sder.2016.031
Keywords
-
Categories
Ask authors/readers for more resources
Propionibacterium acnes is a key pathogenic factor in the development of acne. Antibiotics are the first choice of treatment for mild-to-moderate, mixed, papular/pustular, and moderate nodular acne, and an alternative choice in severe, nodular/conglobate acne.The emergence of resistance to the currently available antibiotics poses a serious set-back to this algorithm, and the reduced arsenal can diminish efficacy of treatment. This emerging situation should catalyze innovations in dermatology; for example, newer drugs and technologies such as next-generation antibiotics with excellent potency and low propensity to develop resistance, rapid diagnostic platforms to select responders and nonresponders, and delivery technologies that target the bacteria. such innovations can dramatically expand the arsenal for dermatologists in the management of acne. (C) 2016 Frontline Medical Communications
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available